- Emerging mechanisms progress of colorectal cancer liver metastasis
Wenhu Zhao et al, 2022, Frontiers in Endocrinology CrossRef - The Role of HGF/MET in Liver Cancer
Gaurav Gupta et al, 2021, Future Medicinal Chemistry CrossRef - Spatial Transcriptomic Profiling of Tetraspanins in Stage 4 Colon Cancer from Primary Tumor and Liver Metastasis
Thanawat Suwatthanarak et al, 2024, Life CrossRef - The tumor-immune ecosystem in shaping metastasis
Yang Gao et al, 2023, American Journal of Physiology-Cell Physiology CrossRef - ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation
Luisa Gesualdi et al, 2023, Biomedicines CrossRef - Joint DNA-RNA-based NGS for diagnosis and treatment of a rare CD47-MET fusion lung adenocarcinoma which was immunoresistant and savoltinib-sensitive: a case report
Rulan Wang et al, 2024, Frontiers in Immunology CrossRef - Multilevel Heterogeneity of Colorectal Cancer Liver Metastasis
Hao Chen et al, 2023, Cancers CrossRef - Distribution of Metastases in the Organs of Mice after Orthotopic Injection of CT26 Colorectal Cancer Cells
L. S. Kuznetsova et al, 2022, Cell and Tissue Biology CrossRef - Impact of immunotherapy on liver metastasis
Zhuo Fu et al, 2024, World Journal of Gastrointestinal Surgery CrossRef - Multilevel mechanism of immune checkpoint inhibitor action in solid tumors: History, present issues and future development (Review)
Natalya Lisovska, 2022, Oncology Letters CrossRef - Recent advances in targeted drug delivery systems for resistant colorectal cancer
Masoumeh Sharifi-Azad et al, 2022, Cancer Cell International CrossRef - Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
Eiji Takeuchi et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef - CXCR4 promotes gefitinib resistance of Huh7 cells by activating the c‐Met signaling pathway
Dali Zhao et al, 2021, FEBS Open Bio CrossRef - Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer
Parham Jabbarzadeh Kaboli et al, 2024, Cancer Letters CrossRef